Authors


By Lynda Charters; reviewed by Tsontcho Ianchulev, MD, MPH

Latest:

AAO 2023: Suprachoroidal outflow enhancement without implantable hardware: surgical technique and clinical results of a novel supraciliary MIGS

Investigators found that ab-interno implantation of a supraciliary allograft bio-tissue successfully reduced intraocular pressure with comparable safety to other minimally invasive glaucoma surgical procedures


Lourens van Zyl, MBChB, FCOphth, FRANZCO, FRCSI, FEBO, MMed (RefCatSurg), FWCRSVS

Latest:

To Infinity and (PRES)BYOND - The game changer for my practice

Lourens van Zyl wanted to set himself apart in a highly competitive surrounding and saw a potential for practice building by offering solutions for presbyopia in patients without cataract. Within a few years this group became a significant segment of his practice in total share. ZEISS PRESBYOND was the game changer for a business success story.



Dr Amir Rosenblatt

Latest:

Assessing barriers to retinal care during a pandemic

A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.


Alfredo Sadun, MD, PhD

Latest:

ARVO 2025: Alfredo Sadun, MD, PhD, says "later is better" for some LHON interventions

At the 2025 ARVO annual meeting, Prof Sadun shared an exciting update in our understanding of Leber hereditary optic neuropathy


Dr Inder Paul Singh
Dr Inder Paul Singh

Latest:

Simplifying glaucoma medical therapy for patients in the United States

Compounded medications are playing a central role in the process.


Dr Jorge L. Alió and Dr Elinor Megiddo-Barnir

Latest:

Extended depth-of-focus IOLs: A review

A look at how EDOF technology can be categorised into five types


Dr Rishi Raj Borah

Latest:

Orbis brings school-based eye health intervention to children in India

The nonprofit's Refractive Error Among Children programme allows for early detection, prevention and appropriate management of visual impairment.


Michael W. Stewart, MD

Latest:

Impact of Durable Therapies on Patients and Clinics and Monitoring Strategies

Panelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.


Dr Frank J. Goes

Latest:

Half a century of developments in ophthalmology: One doctor’s reflections

Dr Goes reflects on a life at the forefront of ophthalmology, considering advancements in technology and the knowledge that has changed his practice and improved outcomes for patients.


Kassi Filkins

Latest:

Topline results from investigational nAMD drop SYL1801 (Sylentis)

Three dose level cohorts of the small interfering RNA therapeutic were evaluated in a double-blind study


Louise Gagnon; Reviewed by Dr Rachel Curtis

Latest:

Smartphone direct ophthalmoscope tech helps visualise optic disc

A smartphone direct ophthalmoscope attachment makes it possible to examine the optic nerve and distinguish whether its state of health is normal or abnormal.


Hattie Hayes; Reviewed by Norbert Pfeiffer, MD

Latest:

Why the future of glaucoma care is in the operating room

Smaller surgeries, in greater numbers, await new glaucoma specialists


John Kitchens, MD

Latest:

Impact of Durable Therapies on Patients and Clinics and Monitoring Strategies

Panelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.


Palla Deepika

Latest:

Insights into neovascular glaucoma: Pathogenesis and detection of diabetic retinopathy

Management of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents


Benson S. Chen, MBChB, MSc, FRACP

Latest:

The ins and outs of gene therapy for inherited optic neuropathies

A look at what’s in the therapeutic delivery pipeline for these disorders.


Lourens van Zyl, MBChB, FCOphth, FRANZCO, FEBO, FRCSI, FWCRS, MMed(RefCatSurg)

Latest:

An alternative approach to spectacle independence

Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs


Prof. Jorge Alio

Latest:

Cosmetic surgery of the cornea: A new type of surgery

A colourful look at how the keratopigmentation technique offers therapeutic and cosmetic applications.



Mr Mayank A. Nanavaty

Latest:

Not just for eating: Grapes and potatoes help surgery trainees hone skills

The pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.



Dr Lisa M. Nijm

Latest:

Rethinking dry eye disease with acute steroid treatment

Loteprednol etabonate suspension 0.25% demonstrates anti-inflammatory action and produces significant improvement in conjunctival hyperaemia and ocular discomfort.


Dr Hasan Naveed

Latest:

Not just for eating: Grapes and potatoes help surgery trainees hone skills

The pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.


Reviewed by Tamara Wygnanski-Jaffe, MD; and Nicholas Sala, DO

Latest:

A new home treatment for amblyopia

Binocular eye tracking could serve as alternative to patching and provide visual acuity gains with heightened adherence rates



Prof István Szabó

Latest:

Amblyopia screening with the dynamic random dot stereotest

A new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.



Tobias Gutzeit, BSc

Latest:

The ZEISS IOL Power Calculation Service. Providing guidance in complex cases

Advances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.


Elana Meer, BA

Latest:

Electronic health records: how the pandemic highlighted the future of practice management

Electronic health records may be the future of practice management.


Marco Zarbin, MD, PhD, FACS

Latest:

Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trials in nAMD

Dr Marco Zarbin presents his talk from the 2023 ASRS annual meeting, where he explores the impact of disease activity criteria on drug durability estimations in clinical trials and includes a comparative analysis across multiple clinical trials in neovascular AMD (age-related macular degeneration).

© 2025 MJH Life Sciences

All rights reserved.